Home Science MIRAM® Kit Clinical Studies News Team Careers Contact

We proudly sponsor a series of clinical studies to evaluate our liquid biopsy across cancers

LEVANTIS-0087A

Multi-Cancer Early Detection in Asymptomatic Adults

LEVANTIS-0087A (LEV87A) is a retrospective population cohort-based nested case-control study to validate the performance of the free GAGome-based MCED tests in adults asymptomatic for cancer with no recent history of cancer.

LEVANTIS-0093A

Multi-Cancer Early Detection in High-Risk Adults

LEVANTIS-0093A (LEV93A) is a prospective observational cohort study to validate the performance of the plasma free GAGome MCED test in 55 to 80 years old adults with significant smoking history and thus at high risk of developing cancer (“high-risk adults”).

LEVANTIS-0065

Multi-Cancer Early Detection in Firefighters

LEVANTIS-0065 (LEV65) is a prospective observational cohort study to explore the performance of the combined free GAGome MCED test in adults who are actively employed as firefighters in comparison to other MCED tests.

AURORAX-0087A

Surveillance for Clear Cell Renal Cell Carcinoma Recurrence

AURORAX-0087A (AUR87A) is a prospective multi-center observational cohort study to validate the performance of the urine free GAGome RCC test for the early detection of recurrence after curative intent surgery in patients with high or intermediate risk clear cell renal cell carcinoma.

AURORAX-0093A

Prognosis of Muscle-Invasive Bladder Cancer

AURORAX-0093A (AUR93A) is a prospective observational cohort study to develop free GAGome-based tests for the prognosis of muscle-invasive bladder cancer patients elected for neo-adjuvant chemotherapy before radical cystectomy.

Backed by